
==== Front
Sci Rep
Sci Rep
Scientific Reports
2045-2322
Nature Publishing Group UK London

39245762
72140
10.1038/s41598-024-72140-5
Article
Nine-year survival after intertrochanteric fracture in elderly with chronic kidney disease
https://orcid.org/0000-0001-7903-9685
Phruetthiphat Ong-art ophruetthiphat@gmail.com
ongart-phr1@hotmail.com

1
Lawanprasert Attaporn 2
Satravaha Yodhathai 3
Pinijprapa Panukorn 1
Songpatanasilp Thawee 1
Pongchaiyakul Chatlert 4
1 https://ror.org/007h1qz76 grid.414965.b 0000 0004 0576 1212 Department of Orthopaedics, Phramongkutklao Hospital and College of Medicine, 315 Ratchawidhi Rd, Thung Phaya Thai, Ratchathewi, Bangkok, 10400 Thailand
2 https://ror.org/01qc5zk84 grid.428299.c 0000 0004 0578 1686 Department of Orthopaedics, Chulabhorn Hospital, Bangkok, Thailand
3 https://ror.org/01znkr924 grid.10223.32 0000 0004 1937 0490 Department of Orthodontics, Faculty of Dentistry, Mahidol University, Bangkok, Thailand
4 https://ror.org/03cq4gr50 grid.9786.0 0000 0004 0470 0856 Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
8 9 2024
8 9 2024
2024
14 2091216 4 2024
4 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
The outcome of this study was to identify 9-year survivors of intertrochanteric fracture at each stage of chronic kidney disease (CKD) and to investigate the risk factors associated with mortality following surgery with proximal femoral nail anti-rotation (PFNA). 443 elderly intertrochanteric fractures underwent PFNA fixation were recruited. Mortality rate was identified until 9 years. We compared the survival time of hip fracture in each stage of CKD. A regression analysis was used to determine the association between risk factors and one-year mortality. The overall median survival time was 7.1 years. The Kaplan–Meier curve was significantly different in each CKD stage especially in CKD5. In addition, the incidence rate of mortality was highest in CKD 5 (17.4%) and the median survival time in CKD 5 was 3.3 years. The multivariate analysis demonstrated that heart disease, operative time > 60 min, presence of pulmonary embolism, and poor to fair Harris hip score were significantly increased mortality. CKD stage 5 is associated with the highest mortality rate and the shortest median time of survival during the 9-year follow up. Patients who have high risk should focus on long-term care planning, including the counseling for their healthcare providers and families.

Keywords

Chronic kidney disease
Harris hip score
Intertrochanteric fracture
Regression analysis
Survival analysis
Subject terms

Diseases
Health care
Medical research
issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcOsteoporotic hip fracture is becoming a major public health concern as the world’s population ages1,2. It has been demonstrated that fragility hip fracture affects ambulatory status, quality of life, functional outcomes, mortality, and resource and financial costs spent in the health care system3–6. The mortality rate of osteoporotic hip fracture has risen for at least ten years afterward, with 1-year cumulative mortality ranging from 20 to 40%7–9.

Previous studies found that older age, male gender, co-morbidities (such as liver disease, chronic kidney disease, and heart pathology), and a Charlson index greater than 2 were all associated with an increased risk of mortality10–14. However, they were primarily concerned with the mortality rate (within 1 and 2 years after hip fracture). It is well known that glomerular filtration rate decreases with age, and chronic kidney disease (CKD) is more severe in the elderly15. Mataliotakis and associates found that patients with end-stage renal disease (ESRD) had a 4.4-fold increased risk of hip fracture when compared to the general population16. Furthermore, patients with a hip fracture and renal problem had a significantly higher mortality rate17–19. Moreover, Intertrochanteric fractures in patients with advanced CKD was associated with increased one-year mortality13. Acute kidney injury and advanced CKD in the intertrochanteric fracture were significantly associated with increased one-year mortality, according to Kim and colleagues13. However, there is a scarcity of data on long-term survivors of elderly hip fractures combined with CKD. As a result, the primary objective of this study was to determine 9-year survivors of hip fractures at each stage of CKD. The secondary objective was to investigate the risk factors associated with mortality following hip fracture surgery with proximal femoral nail anti-rotation.

Material and methods

Setting and subjects

A retrospective study was conducted on elderly patients with intertrochanteric fractures sustained from low energy trauma and treated surgically with proximal femoral nail anti-rotation (PFNA) between December 2011 and December 2019, using the database of department of orthopaedics at Phramongkutklao hospital. Patients with high-energy trauma, multiple fractures, pathological fractures, who were referred to other hospitals after surgery, or who had incomplete medical records, including no functional outcome assessment by Harris Hip Score (HHS), were excluded from the study. The Institutional Research Board of Royal Thai Army Hospital reviewed and approved the study as per the Helsinski Declaration and the Good Clinical Practice Guidelines (S032h/64 and 353/2022). All eligible patients signed informed consent before enrollment.

Measurements

Demographic data and comorbidities including age, gender, body weight, height, body mass index (BMI), underlying diseases (hypertension, diabetes mellitus, dyslipidemia, cardiovascular disease, gout, chronic kidney disease), Charlson comorbidity index (CCI), surgical parameters (operative time and operative blood loss), functional outcomes, and complications (hematoma, pulmonary embolism) were collected and obtained from the electronic medical record. In all patients, the estimated glomerular Infiltration rate (eGFR) was calculated using the chronic kidney disease-epidemiology collaboration (CKD-EPI) Eq. 20, and the classification of CKD was defined as the international guideline group Kidney Disease Improving Global Outcomes (KDIGO) in 201221 and 201722. In this study, patients were classified as having chronic kidney disease (CKD) if their eGFR was less than 90 ml/min/1.73 m2 and non-CKD if eGFR was greater than 90 ml/min/1.73 m2. Furthermore, mortality was assessed 1 year, 3 years, 5 years, and 9 years after surgical fixation with proximal femoral nail anti-rotation (PFNA).

Surgical technique

All patients with intertrochanteric fractures who received proximal femoral nail anti-rotation (PFNA) fixation had surgery by three highly qualified orthopedic traumatologists: T.J., O.P., and Y.P. All orthopedic surgeons used the same standard procedure for fracture reduction. We all used the fracture table to help us reduce fractures percutaneously (closed reduction). However, in some cases when achieving precise reduction by closed approach proved challenging, we all considered performing a mini-open skin incision about 7 cm from the vastus ridge to the subtrochanteric region. The Homann retractor or bone hook was used on the lesser trochanter. Fluoroscopy was used to examine the fracture gap, step, and alignment in both anteroposterior and lateral views. Kirchner wires were subsequently applied to the fracture site to maintain the perfect reduction. A long guidewire was inserted into the intramedullary canal. The position of the wire was then verified using fluoroscopy in both anteroposterior (AP) and lateral views. The PFNA was subsequently inserted along the guidewire. The blade was passed from the lateral wall to the femoral head, and the appropriate tip and apex distances23 were confirmed before tightening the blade system. Finally, the distal screw was inserted.

Operational definition and outcomes

The survival time is the time from the admission to death, the incidence of mortality (failure) is any deaths during the study period, and the living patients who loss contact or had an unknown status during the study period were defined as censor observation. All patients were seen in clinic at 2 weeks, 6 weeks, 3 months, 6 months, 9 months, 1 year, and every year until 9 years. At one year after surgical fixation, all patients’ functional outcomes were assessed using Harris Hip Score (HHS). Pain (44 points), limp (11 points), support (11 points), distance walked (11 points), sitting (5 points), entering public transportation (1 point), stairs (4 points), putting on socks and shoes (4 points), absence of deformity (4 points), and range of motion (5 points) are all components of HHS. The lowest HHS is represented by zero points, while the highest HHS is represented by one hundred points24. The mortality rate in each stage of CKD was assessed. We also compared the median survival time of hip fracture patients over 60 years in each stage of CKD over a 9-year period.

Statistical analysis

All statistical analyses were calculated using STATA version 14.0 (Stata Corp., College Station, TX, USA). Descriptive statistics are used to categorize and summarize demographic data. Continuous data were presented as means with standard deviation (SD) or medians with minimum and maximum value, as appropriate. Categorical data were presented as frequency and percentage. Comparison of categorical variables, the Chi-square test or Fisher’s exact test or Fisher’s exact test were used, as appropriate. All continuous variables were tested for the normality using a Shapiro–Wilk test and were compared using the Student’s t test or Mann–Whitney U test, as appropriate. Kaplan–Meier curve was used to estimate the overall and each stage survival probability in CKD.

Result

In this study, 443 elderly patients with intertrochanteric fractures were recruited. The mean age and BMI, as shown in Table 1, were 80.6 ± 8.5 years and 22.4 ± 3.8 kg/m2, respectively. There were 319 (72.0%) female patients and 404 (91.2%) patients with CKD (eGFR 90 ml/min/1.73 m2). In the comparison of CKD and non-CKD groups, as shown in Table 2, CKD patients were significantly older, had lower BMI, and had a higher rate of ASA class III than non-CKD patients. Gender, diabetes mellitus, hypertension, CCI, operative time, hip BMD, time to walk, length of hospital stays, surgical and medical complications, and one-year HHS did not differ between groups.Table 1 Baseline characteristics of patients with intertrochanteric fracture.

Characteristics	All patients (n = 443)	
Female sex, n (%)	319 (72.0%)	
Age at time of surgery (years), mean ± SD	80.6 ± 8.5	
Body mass index (kg/m2), mean ± SD	22.4 ± 3.81	
Hypertension, n (%)	310 (70.0%)	
Type 2 DM, n (%)	134 (30.3%)	
Chronic kidney disease (CKD), n (%)	
 Non CKD (eGFR ≥ 90)	39 (8.8%)	
 CKD (eGFR < 90)	404 (91.2%)	
ASA class	
 I–II	138 (31.1%)	
 III	305 (68.9%)	
CCI, mean ± SD	4.69 ± 1.62	
  ≤ 5	315 (71.1%)	
  > 5	128 (28.9%)	
ASA American Society of Anesthesiologists, CCI Charlson comorbidity index.

Table 2 Comparison of demography, comorbidity, outcome, and complications between non-CKD and CKD groups.

Characteristics	Total (N = 443)	Non-CKD (N = 39) (eGFR ≥ 90)	CKD (N = 404) (eGFR < 90)	p-value	
Gender, n (%)	0.127	
 Male	124 (28.0%)	15 (38.5%)	109 (27.0%)		
 Female	319 (72.0%)	24 (61.5%)	295 (73.0%)		
Age, mean ± SD	80.6 ± 8.5	74.2 ± 8.2	81.2 ± 8.3	 < 0.001	
Body mass index (kg/m2), mean ± SD	22.4 ± 3.8	24.9 ± 4.1	22.2 ± 3.7	 < 0.001	
ASA class, n (%)	0.002	
 I–II	138 (31.1%)	22 (56.4%)	116 (28.7%)		
 III	305 (68.9%)	17 (43.6%)	288 (71.3%)		
Type II Diabetes mellitus, n (%)	0.421	
 No	309 (69.75)	25 (64.10)	284 (70.30)		
 Yes	134 (30.25)	14 (35.90)	120 (29.70)		
Hypertension, n (%)	0.116	
 No	133 (30.02)	16 (41.03)	117 (28.96)		
 Yes	310 (69.98)	23 (58.97)	287 (71.04)		
CCI, mean ± SD	4.7 ± 1.6	4.0 ± 1.6	4.8 ± 1.6	0.227	
  ≤ 5	315 (71.1%)	31 (79.5%)	284 (70.3%)		
  > 5	128 (28.9%)	8 (20.5%)	120 (29.7%)		
Bone mineral density at non-fracture hip (g/cm2), mean ± SD	 − 2.962 ± 0.709	 − 3.033 ± 0.669	 − 2.956 ± 0.714	0.628	
Operative time (minutes), mean ± SD	69.7 ± 19.9	79.7 ± 26.5	68.7 ± 18.8	0.166	
Time to walk (days), mean ± SD	9.5 ± 9.0	10.0 ± 7.3	9.5 ± 9.2	0.267	
 ≤ 5	137 (30.93)	9 (23.08)	128 (31.68)		
 > 5	306 (69.07)	30 (76.92)	276 (68.32)		
Length of stay (days), mean ± SD	16.8 ± 10.6	18.0 ± 8.9	16.7 ± 10.8	0.618	
Surgical complication, n (%)	12 (3.0%)	1 (2.8%)	11 (3.1%)	1.000	
Medical complication, n (%)	33 (8.3%)	3 (8.3%)	30 (8.3%)	1.000	
One year HHS, mean ± SD	87.2 ± 7.9	86.6 ± 8.9	87.2 ± 7.8	0.651	
ASA class American society of anesthesiologist class, CCI Charlson comorbidity index, HHS Harris hip score.

Surgical complication includes surgical site infection, hematoma, and deep infection while medical complication includes pneumonia, sepsis, urinary tract infection, venous thromboembolism, and heart failure.

Significant values in bold.

The overall mortality rate in this cohort was 42.4% (188 patients), a total follow-up time of 1717.96 person-year. The incidence of mortality was 10.94 per 100 person-year (95%CI 9.49–12.62), with a median survival time of 7.07 years (95% CI 5.89–8.59). Figure 1 shows that the survival rate after surgical fixation for intertrochanteric fracture decreased with time (89.6%, 74.1%, 59.9%, and 37.8% at 1, 3, 5, and 9 years, respectively). We found that the mortality rates differed depending on the stage of CKD (Fig. 2). Furthermore, as shown in Table 3, the incidence rate of one-year mortality was highest in CKD stage 5 (17.4% with 95% CI 11.76–25.75) and the median survival time was 3.34 years (95% CI 2.17–7.50).Fig. 1 The Kaplan–Meier survival curve after hip fracture from 1 and 9 years (89.6%, 74.1%, 59.9%, and 37.8% at 1, 3, 5, and 9 years, respectively).

Fig. 2 The comparison of Kaplan–Meier survival curve among each stage of CKD after hip fracture from 1 and 9 years.

Table 3 Mortality, incidence rate, and median time of survival based on CKD stages.

CKD staging and mortality	Total number	Number of deaths	Person-year	Incident rate (%) (95% CI)	Median time (years) (95% CI)	
Overall Mortality*	443	188	1717.96	10.94 (9.49—12.62)	7.07

(5.89–8.59)

	
Non-CKD (Stage 1)	39	20	157.59	12.69 (8.19–19.67)	5.75

(2.69–N/A)

	
CKD Stage 2	162	76	673.02	11.29 (9.02–14.14)	5.98

(4.59–N/A)

	
CKD Stage 3a	88	39	363.3	10.73 (7.84–14.69)	7.10

(4.34–N/A)

	
CKD Stage 3b	75	20	343.61	5.82 (3.76–9.02)	N/A	
CKD Stage 4	38	8	164.49	4.86 (2.43–9.73)	N/A	
CKD Stage 5	41	25	143.7	17.40 (11.76–25.75)	3.34 (2.17–7.50)	
Overall mortality after elderly hip fracture was 42.4% (188 patients).

*Mortality was 10.4% at 1 year, 25.9% at 3 years, 40.1% at 5 years and 62.2% at 9 years after surgical fixation for osteoporotic hip fractures.

95% CI 95% Confidential Interval.

N/A not applicable when deceased patients were less than 50%.

A logistic regression analysis was used to determine the association between risk factors and one-year mortality, as demonstrated in Table 4. In univariate analysis, patients with CKD stage 5, operative time longer than 60 min, and the presence of a pulmonary embolism were associated with one-year mortality. Despite CKD stage 5 was not significantly increased mortality following surgical fixation of a hip fracture according to the multivariate analysis (p = 0.072), but other factors including heart disease, an operative time > 60 min, the presence of a pulmonary embolism, and poor to fair functional outcomes using HHS were significantly increased mortality (Table 4).Table 4 Univariate and multivariate regression analysis of risk factors and increased mortality after hip fracture.

Comorbidity/complication	Univariate analysis	Multivariate analysis	
Hazard ratio (95% CI)	p-value	Hazard ratio (95% CI)	p-value	
Comorbidities	
 Heart disease (Yes vs. No*)	1.33 (0.97–1.83)	0.077	1.63 (1.05–2.51)	0.028	
 CKD stage (CKD 5 vs. CKD 1–4*)	1.82 (1.20–2.78)	0.005	0.60 (0.35–1.05)	0.072	
Operative time

 (> 60 min vs. ≤ 60 min*)

	1.89 (1.40–2.56)	 < 0.001	1.51 (1.08–2.10)	0.015	
Complications	
 Hematoma (Yes vs. No*)	3.72 (0.52–26.72)	0.191	7.09 (0.95–53.19)	0.057	
 Pulmonary embolism (Yes vs. No*)	9.37 (1.29–68.14)	0.027	20.35 (2.36–175.51)	0.006	
 Functional outcome (HHS)

Poor to Fair vs. Good to Excellent*

	1.11 (0. 77–1.58)	0.582	1.58 (1.01–2.46)	0.043	
95% CI 95% confidence interval; CKD chronic kidney disease; HHS Harris hip score.

*Reference.

Significant values in bold.

Discussion

ESRD was strongly associated with an increase in mortality rate17–19, and intertrochanteric fracture with advanced CKD was significantly associated with an increase in one-year mortality13. However, there is a lack of data on long-term survivors after hip fracture combined with CKD in elderly patients. In this study, we found that the mortality rate in elderly with intertrochanteric fracture was 10.4%, 25.9%, 40.1% and 62.2% at 1, 3, 5 and 9 years after surgical fixation. The current study’s one-year mortality rate for osteoporotic hip fracture in current study was lower than previous studies, which reported ranging from 20 to 40%7–9. One possible explanation is that elderly hip fractures in our facility were treated by a multidisciplinary team and received early rehabilitation.

The rate of survival after surgical fixation for an intertrochanteric fracture decreased over time, according to our findings. Non-CKD, CKD stage 2, and CKD stage 3a had median survival times of 5.75, 5.98, and 7.10 years, respectively. Furthermore, the median survival time was 3.34 years, and one-year mortality was highest in CKD stage 5 (17.4%), as previously reported17–19,29. Ramamurti and colleagues discovered that CKD stages 4 and 5 were significantly associated with increased mortality and all complications after surgical fixation for hip fracture compared to non-CKD25. Furthermore, LJ Hickson and associates demonstrated that CKD stage 5 patients on dialysis had a significantly higher in-hospital mortality (OR 2.65) and 30-day mortality (OR 2.03) compared to non-dialysis patients26.

We found that CKD stage 5, operative time greater than 60 min, and the presence of pulmonary embolism during admission are associated with mortality in univariate analysis, while heart diseases, operative time greater than 60 min, the presence of pulmonary embolism during admission, and a lower HHS at 1 year follow up are associated with mortality in multivariate analysis. This finding was consistent with the previous researches, which found that a number of factors, including liver diseases, chronic kidney disease, heart pathology, and the Charlson index were associated with increased mortality10–14. Previous studies, on the other hand, mainly identified several medical factors that were significantly associated with increased mortality after surgical fixation for hip fracture, whereas our study included surgical factor (operative time), pulmonary embolism, and functional outcome assessed by HHS.

The primary goal of risk factors is to identify patients with intertrochanteric fracture who are at high risk of death. Previous research has found that advanced stage CKD, time to surgery, rehabilitation status, post-operative complications, and previous ambulatory status all have an impact on functional status after hip fractures13,16–19,27–30. Furthermore, this study discovered that elderly patients with intertrochanteric fracture demonstrating a heart disease, a longer operative time, a pulmonary embolism, and a poor to fair functional outcome were associated with increased mortality. As a result, improving these modifiable risk factors, such as special assessment by a highly experienced cardiologist, surgery with a shorter operative time, venous thromboembolism prevention, and improved functional outcome through good surgical technique and rehabilitation program, may increase the survival rate.

This study should be interpreted in the context of a number of potential strengths and weaknesses. The strength of this study derives from its 9 years survival analysis of long-term data, which increases the ability to determine the risk factor over a longer period of time. In addition, the database collected information from a single center with an adequate sample size and also included accurate mortality information from civil registration. However, this study cannot confirm the mortality rate for each stage of CKD, with the exception of CKD stage 5 and the non-CKD group. Because our sample size was insufficient to provide sufficient data on earlier stages of CKD, the effect of CKD on other stages (stage 2, 3a, 3b, and 4) was comparable to that of the non-CKD group. This study did not identify the association between mortality and patients with CKD stage 5 on dialysis, despite the fact that a previous study26 demonstrated that this parameter significantly increased in-hospital and 30-day mortality. The study may have unintentionally recruited patients with greater survival rates or outcomes because healthier patients were more likely to participate in the study; therefore, bias may skew the results and limit generalizability. The missing data may occur because the follow-up study period was long (9 years), leading in an underestimation or overestimation of the survival rate. In this study, the CKD stage was classified based on the initial serum creatinine test and eGFR calculation performed prior to surgical operations. There could have been issues concerning classifying patients into different CKD stages, particularly when renal function differed over time. In addition, this study was limited by the lack of information regarding socioeconomic status, individual healthcare practices, and specific drugs, all of which are possible variables that could influence the relationship between chronic kidney disease (CKD) and survival.

In conclusion, during a 9-year follow-up, CKD stage 5 was associated with the highest mortality rate and shortest median survival time. In addition, heart disease, a longer operative time, pulmonary embolism, and poor to fair HHS were associated with increased risk of mortality. Recognizing these risk factors for mortality following fragility hip fracture could increase surgeons’ awareness of this vulnerable population. Patients who are at a greater risk should prioritize long-term care planning, including counseling for their healthcare providers and families.

Abbreviations

CKD Chronic kidney disease

non-CKD Non chronic kidney disease

PFNA Proximal femoral nail anti-rotation

ESRD End-stage renal disease

BMI Body mass index

CCI Charlson comorbidity index

CKD-EPI Chronic kidney disease-epidemiology collaboration

KDIGO Kidney disease improving global outcomes

HHS Harris hip score

ASA class American society of anesthesiologists classification

SD Standard deviation

95% CI 95% Confidential interval

OR Odd ratio

Acknowledgements

The authors thank the patients for their participation. We also thank Pawinee Saybungkla for statistical analyses.

Author contributions

All authors designed the protocol, read, and approved the final manuscript. O.P. Generating the idea, collecting data, analyzing the data, and writing the manuscript. A.L., Y.S., and P.P. collecting data, sorted out the material and assisting in the discussion part. T.S. supervised the study and assisting in the discussion part. C.P. supervised the study, checked and revising the manuscript. All authors have read and approved the final submitted manuscript.

Data availability

The datasets used during the current study available from the corresponding author on reasonable request.

Competing interests

The authors declare no competing interests.

Ethical approval

The study was approved by the Institutional Review Board Royal Thai Army Medical Department (IRBRTA). All procedures were performed in accordance with relevant guidelines. This study was registered to IRBRTA and it has been approved with a code of S032h/64 and 353/2022. Informed consent was obtained from all individual participants included in the study.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Cooper C Campion G Melton LJ 3rd Hip fractures in the elderly: A world-wide projection Osteoporos. Int. 1992 2 6 285 289 10.1007/BF01623184 1421796
Cooper, C., Campion, G. & Melton, L. J. 3rd. Hip fractures in the elderly: A world-wide projection. Osteoporos. Int. 2(6), 285–289 (1992).1421796 10.1007/BF01623184
2. Gullberg B Johnell O Kanis JA World-wide projections for hip fracture Osteoporos. Int. 1997 7 5 407 413 10.1007/PL00004148 9425497
Gullberg, B., Johnell, O. & Kanis, J. A. World-wide projections for hip fracture. Osteoporos. Int. 7(5), 407–413 (1997).9425497 10.1007/PL00004148
3. Johnell O Kanis JA An estimate of the worldwide prevalence, mortality and disability associated with hip fracture Osteoporos. Int. 2004 15 11 897 902 10.1007/s00198-004-1627-0 15490120
Johnell, O. & Kanis, J. A. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos. Int. 15(11), 897–902 (2004).15490120 10.1007/s00198-004-1627-0
4. Johnell O Kanis JA An estimate of the worldwide prevalence and disability associated with osteoporotic fractures Osteoporos. Int. 2006 17 12 1726 1733 10.1007/s00198-006-0172-4 16983459
Johnell, O. & Kanis, J. A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos. Int. 17(12), 1726–1733 (2006).16983459 10.1007/s00198-006-0172-4
5. Burge R Dawson-Hughes B Solomon DH Wong JB King A Tosteson A Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025 J. Bone Miner. Res. 2007 22 3 465 475 10.1359/jbmr.061113 17144789
Burge, R. et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J. Bone Miner. Res. 22(3), 465–475 (2007).17144789 10.1359/jbmr.061113
6. O'Neill TW Roy DK How many people develop fractures with what outcome? Best Pract. Res. Clin. Rheumatol. 2005 19 6 879 895 10.1016/j.berh.2005.06.003 16301185
O’Neill, T. W. & Roy, D. K. How many people develop fractures with what outcome?. Best Pract. Res. Clin. Rheumatol. 19(6), 879–895 (2005).16301185 10.1016/j.berh.2005.06.003
7. Cummings SR Melton LJ Epidemiology and outcomes of osteoporotic fractures Lancet. 2002 359 9319 1761 1767 10.1016/S0140-6736(02)08657-9 12049882
Cummings, S. R. & Melton, L. J. Epidemiology and outcomes of osteoporotic fractures. Lancet. 359(9319), 1761–1767 (2002).12049882 10.1016/S0140-6736(02)08657-9
8. Kanis JA Oden A Johnell O De Laet C Jonsson B Oglesby AK The components of excess mortality after hip fracture Bone. 2003 32 5 468 473 10.1016/S8756-3282(03)00061-9 12753862
Kanis, J. A. et al. The components of excess mortality after hip fracture. Bone. 32(5), 468–473 (2003).12753862 10.1016/S8756-3282(03)00061-9
9. Katsoulis M Benetou V Karapetyan T Excess mortality after hip fracture in elderly persons from Europe and the USA: The CHANCES project J. Intern. Med. 2017 281 3 300 310 10.1111/joim.12586 28093824
Katsoulis, M. et al. Excess mortality after hip fracture in elderly persons from Europe and the USA: The CHANCES project. J. Intern. Med. 281(3), 300–310 (2017).28093824 10.1111/joim.12586
10. Haentjens P Magaziner J Colón-Emeric CS Meta-analysis: Excess mortality after hip fracture among older women and men Ann. Intern. Med. 2010 152 6 380 390 10.7326/0003-4819-152-6-201003160-00008 20231569
Haentjens, P. et al. Meta-analysis: Excess mortality after hip fracture among older women and men. Ann. Intern. Med. 152(6), 380–390 (2010).20231569 10.7326/0003-4819-152-6-201003160-00008
11. Guzon-Illescas O Perez Fernandez E Crespí Villarias N Mortality after osteoporotic hip fracture: incidence, trends, and associated factors J. Orthop. Surg. Res. 2019 14 1 203 10.1186/s13018-019-1226-6 31272470
Guzon-Illescas, O. et al. Mortality after osteoporotic hip fracture: incidence, trends, and associated factors. J. Orthop. Surg. Res. 14(1), 203 (2019).31272470 10.1186/s13018-019-1226-6
12. Yaacobi E Marom O Gutman N Mortality following surgery for geriatric hip fractures: Is it the timing or the co-morbidities? Hip Int. 2022 32 2 271 275 10.1177/1120700020945942 32718199
Yaacobi, E. et al. Mortality following surgery for geriatric hip fractures: Is it the timing or the co-morbidities?. Hip Int. 32(2), 271–275 (2022).32718199 10.1177/1120700020945942
13. Kim TW Lee SM Moon NH Chronic kidney disease patients with intertrochanteric fracture have a high mortality rate Injury 2021 52 8 2350 2355 10.1016/j.injury.2021.05.045 34134855
Kim, T. W. et al. Chronic kidney disease patients with intertrochanteric fracture have a high mortality rate. Injury 52(8), 2350–2355 (2021).34134855 10.1016/j.injury.2021.05.045
14. Xu BY Yan S Low LL Predictors of poor functional outcomes and mortality in patients with hip fracture: A systematic review BMC Musculoskelet. Disord. 2019 20 1 568 10.1186/s12891-019-2950-0 31775693
Xu, B. Y. et al. Predictors of poor functional outcomes and mortality in patients with hip fracture: A systematic review. BMC Musculoskelet. Disord. 20(1), 568 (2019).31775693 10.1186/s12891-019-2950-0
15. Avin KG Moorthi RN Bone is not alone: The effects of skeletal muscle dysfunction in chronic kidney disease Curr. Osteoporos. Rep. 2015 13 3 173 179 10.1007/s11914-015-0261-4 25691218
Avin, K. G. & Moorthi, R. N. Bone is not alone: The effects of skeletal muscle dysfunction in chronic kidney disease. Curr. Osteoporos. Rep. 13(3), 173–179 (2015).25691218 10.1007/s11914-015-0261-4
16. Mataliotakis G Lykissas MG Mavrodontidis AN Femoral neck fractures secondary to renal osteodystrophy. Literature review and treatment algorithm J. Musculoskelet. Neuronal Interact. 2009 9 3 130 7 19724147
Mataliotakis, G. et al. Femoral neck fractures secondary to renal osteodystrophy. Literature review and treatment algorithm. J. Musculoskelet. Neuronal Interact. 9(3), 130–7 (2009).19724147
17. Lan J Zhang H Sheng R The impact of chronic kidney disease and dialysis therapy on outcomes of elderly patients with hip fractures: A systematic review and meta-analysis Scott. Med. J. 2022 67 4 144 156 10.1177/00369330221112175 35862029
Lan, J. et al. The impact of chronic kidney disease and dialysis therapy on outcomes of elderly patients with hip fractures: A systematic review and meta-analysis. Scott. Med. J. 67(4), 144–156 (2022).35862029 10.1177/00369330221112175
18. Lo LWT Xu Y Howe TS End stage renal disease patients undergoing hip fracture surgery have increased length of stay, acute hospital bill size, and reduced survivorship-implications on a bundled care program Arch. Osteoporos. 2022 17 1 59 10.1007/s11657-022-01103-y 35385992
Lo, L. W. T. et al. End stage renal disease patients undergoing hip fracture surgery have increased length of stay, acute hospital bill size, and reduced survivorship-implications on a bundled care program. Arch. Osteoporos. 17(1), 59 (2022).35385992 10.1007/s11657-022-01103-y
19. Belmont PJ Jr Garcia EJ Romano D Risk factors for complications and in-hospital mortality following hip fractures: A study using the National Trauma Data Bank Arch. Orthop. Trauma Surg. 2014 134 5 597 604 10.1007/s00402-014-1959-y 24570142
Belmont, P. J. Jr. et al. Risk factors for complications and in-hospital mortality following hip fractures: A study using the National Trauma Data Bank. Arch. Orthop. Trauma Surg. 134(5), 597–604 (2014).24570142 10.1007/s00402-014-1959-y
20. Levey AS Stevens LA Schmid CH A new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med. 2011 Sep 20;155(6):408] Ann. Intern. Med. 2009 150 9 604 12 10.7326/0003-4819-150-9-200905050-00006 19414839
Levey, A. S. et al. A new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med. 2011 Sep 20;155(6):408]. Ann. Intern. Med. 150(9), 604–12 (2009).19414839 10.7326/0003-4819-150-9-200905050-00006
21. Andrassy KM Comments on 'KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease' Kidney Int. 2013 84 3 622 623 10.1038/ki.2013.243 23989362
Andrassy, K. M. Comments on “KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease”. Kidney Int. 84(3), 622–623 (2013).23989362 10.1038/ki.2013.243
22. Erratum: Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Kidney Int. Suppl. 2017 2017 7 1 59
Erratum: Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO. Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl. 2017(7), 1–59 (2017).
23. Baumgaertner MR Curtin SL Lindskog DM Keggi JM The value of the tip-apex distance in predicting failure of fixation of peritrochanteric fractures of the hip J. Bone Joint Surg. Am. 1995 77 7 1058 1064 10.2106/00004623-199507000-00012 7608228
Baumgaertner, M. R., Curtin, S. L., Lindskog, D. M. & Keggi, J. M. The value of the tip-apex distance in predicting failure of fixation of peritrochanteric fractures of the hip. J. Bone Joint Surg. Am. 77(7), 1058–1064 (1995).7608228 10.2106/00004623-199507000-00012
24. Harris WH Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation J. Bone Joint Surg. Am. 1969 51 4 737 55 10.2106/00004623-196951040-00012 5783851
Harris, W. H. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J. Bone Joint Surg. Am. 51(4), 737–55 (1969).5783851 10.2106/00004623-196951040-00012
25. Ramamurti P Fassihi SC Sacolick D Impaired renal function is an independent risk factor for complications after surgery for femoral neck fracture Hip Int. 2023 33 2 345 353 10.1177/11207000211028502 34191641
Ramamurti, P. et al. Impaired renal function is an independent risk factor for complications after surgery for femoral neck fracture. Hip Int. 33(2), 345–353 (2023).34191641 10.1177/11207000211028502
26. Hickson LJ Farah WH Johnson RL Death and postoperative complications after hip fracture repair: dialysis effect Kidney Int. Rep. 2018 3 6 1294 1303 10.1016/j.ekir.2018.07.001 30450456
Hickson, L. J. et al. Death and postoperative complications after hip fracture repair: dialysis effect. Kidney Int. Rep. 3(6), 1294–1303 (2018).30450456 10.1016/j.ekir.2018.07.001
27. Roshanravan B Robinson-Cohen C Patel KV Association between physical performance and all-cause mortality in CKD J. Am. Soc. Nephrol. 2013 24 5 822 830 10.1681/ASN.2012070702 23599380
Roshanravan, B. et al. Association between physical performance and all-cause mortality in CKD. J. Am. Soc. Nephrol. 24(5), 822–830 (2013).23599380 10.1681/ASN.2012070702
28. Abellan van Kan G Rolland Y Andrieu S Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force J. Nutr. Health Aging 2009 13 10 881 9 10.1007/s12603-009-0246-z 19924348
Abellan van Kan, G. et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J. Nutr. Health Aging 13(10), 881–9 (2009).19924348 10.1007/s12603-009-0246-z
29. Phruetthiphat OA Paiboonrungroj S Satravaha Y The effect of CKD on intertrochanteric fracture treated with proximal femoral nail anti-rotation: A 7-year study J. Orthop. 2022 32 151 155 10.1016/j.jor.2022.06.003 35733927
Phruetthiphat, O. A. et al. The effect of CKD on intertrochanteric fracture treated with proximal femoral nail anti-rotation: A 7-year study. J. Orthop. 32, 151–155 (2022).35733927 10.1016/j.jor.2022.06.003
30. Phruetthiphat OA Pinijprapa P Satravaha Y An innovative scoring system for predicting an excellent Harris hip score after proximal femoral nail anti-rotation in elderly patients with intertrochanteric fracture Sci. Rep. 2022 12 1 19939 10.1038/s41598-022-24177-7 36402794
Phruetthiphat, O. A. et al. An innovative scoring system for predicting an excellent Harris hip score after proximal femoral nail anti-rotation in elderly patients with intertrochanteric fracture. Sci. Rep. 12(1), 19939 (2022).36402794 10.1038/s41598-022-24177-7
